Global Commercial Strategy (GCS): Senior Manager, Early Commercial Dermatology, Respiratory, and Other Specialty

Role: Senior Manager, Early Commercial Dermatology, Respiratory, and Other Specialty within Pfizer's Inflammation & Immunology (I&I) portfolio, focusing on shaping long-term commercial strategies, portfolio prioritization, and early assessment of pipeline assets. Responsibilities: develop disease-area strategies, support investment decision-making, lead early commercial assessments, and guide external innovation and business development efforts. Collaborate closely with R&D, Medical Affairs, Market Access, Business Analytics, and cross-functional teams to translate scientific and market insights into strategic recommendations. Drive discipline in indication sequencing, evidence generation, and lifecycle planning, leveraging AI tools for efficiency. Qualifications: Bachelor's degree required, MBA or advanced degree preferred; 6+ years in pharma, biotech, or life sciences with experience in strategic planning, portfolio management, or market research. Expertise in dermatology, respiratory, or complex therapeutic areas is favored. Skills include strategic thinking, stakeholder management, and proficiency in leveraging AI-enabled strategies. High-value specifics: focus on early commercialization, pipeline assessment, portfolio strategy, and external innovation within I&I, supporting a pipeline of over 22 clinical studies and significant revenue impact. Location: U.S., with potential relocation support; candidates must be authorized to work in the U.S. No visa sponsorship available. The role emphasizes cross-functional influence, long-range planning, and adoption of AI-native working methods.